DRIVIN G ROWTH - Dr. Reddy's

130
schedule to the balance sheet and profit and loss account
The information required as per clause 4(c) and (d) and notes thereon of part II of Schedule VI to the Companies Act, 1956
14.CAPACITY AND PRODUCTION
a) Licensed capacity, installed capacity and production
As at March 31, 2002 As at March 31, 2001
Class of goods Unit Licensed Installed Actual Licensed Installed Actual
capacity (i) capacity (i) Production capacity capacity Production
Formulations (ii)
Active pharmaceutical
ingredients and
Million units 2,136* 2,136* 1,960 1,572 1,572 1,750
intermediates (API) Tonnes 6,941 3,313 2,427 6,941 3,270 2,363
Generics
Diagnostic
Million units 3,600 3,600 685.9 3,600 3,600 269
Reagents and Kits Units 600,000 600,000 317,246 600,000 600,000 149,439
Biotechnology
* On single shift basis
NOTES:
Grams 370 340 7.05 – – –
i) Licensed and installed capacities are as certified by Management and not verified by the auditors as this is a technical matter.
ii) Actual production of Formulations includes 329.3 million units (previous year: 202.7 million units) produced on loan licensing basis
from outside parties.
15.PARTICULARS OF PRODUCTION, SALE AND STOCK
Opening Stock Production Purchases Sales **
(Rs. thousand)
Closing stock
Quantity Value Quantity Traded goods
(Units)
Value Quantity Value Quantity Value
Formulations
(million units) 239 349,558 1,960 623 742,755 2,505 6,491,034 317 368,406
(326) (303,930) (1,750) (460) (344,022) (2,297) 5,117,946 (239) (349,558)
Active pharmaceutical
ingredients and
intermediates (Tonnes) 109 135,281 2,427 206 187,736 2,639* 5,885,707 103 209,915
(38) (44,280) (2,363) (30) (22,436) (2,322) (4,314,746) (109) (135,281)
Generics
(million units) – – 685.9 – – 675.5 4,066,417 10.4 5,298
Diagnostic machinery,
reagent kits, controls
standards and analytical
– – (269) – – (269) (304,211) – –
reagents (units) 14,219 8,164 317,246 849,006 37,730 1,158,072 143,384 22,399 12,172
Biotechnology
(17,101) (13,498) (149,439) (25,279) (9,991) (177,600) (104,160) (14,219) (8,164)
(grams) – – 7.05 – – 6.17 37,503 0.88 1,363
Total
Less: intersegmental
493,003 968,221 16,624,045 597,154
sales 1,046,245
Net sales as per
profit and loss account 15,577,800
Previous year (361,708) (376,449) (9,841,063) (493,003)
* Includes captive consumption of Active Pharmaceuticals Ingredient. 160.32 Tonnes (previous year: 146.66 Tonnes)
** Sales are net of samples, rejections and damages but include intersegmental sales.
Figures in brackets represent the numbers for the previous year.
DR. REDDY’S LABORATORIES LTD. | FINANCIALS | ANNUAL REPORT 2001-2002